Steven Coen Biography and Net Worth

Chief Financial Officer of Ginkgo Bioworks

Steve Coen joined Ginkgo on May 1, 2023 with over 30 years of public accounting and corporate finance leadership experience, most recently with Charles River Laboratories, a global contract research organization for pharmaceutical and biotechnology companies, government agencies and leading academic institutions, where he served as the Corporate Vice President & Corporate Controller since May 2017. Prior to Charles River, Steve served in accounting and finance leadership roles in the technology and medical device industries after spending more than 17 years in the audit practice at Deloitte & Touche LLP. Steve earned a B.S. in Accounting and an A.S. in Management from Bentley University and is a Certified Public Accountant in Massachusetts.

What is Steven P. Coen's net worth?: The estimated net worth of Steven P. Coen is at least $62.16 thousand as of October 17th, 2025. Mr. Coen owns 6,738 shares of Ginkgo Bioworks stock worth more than $62,158 as of December 5th. This net worth estimate does not reflect any other investments that Mr. Coen may own. Learn More about Steven P. Coen's net worth.
How do I contact Steven P. Coen?: The corporate mailing address for Mr. Coen and other Ginkgo Bioworks executives is 955 Fifth Avenue, New York NY, 10075. Ginkgo Bioworks can also be reached via phone at 877-442-5362 and via email at [email protected]. Learn More on Steven P. Coen's contact information.
Has Steven P. Coen been buying or selling shares of Ginkgo Bioworks?: Within the last three months, Steven P. Coen has sold $102,043.80 of Ginkgo Bioworks stock. Most recently, Steven P. Coen sold 1,312 shares of the business's stock in a transaction on Friday, October 17th. The shares were sold at an average price of $13.65, for a transaction totalling $17,908.80. Following the completion of the sale, the insider now directly owns 6,738 shares of the company's stock, valued at $91,973.70. Learn More on Steven P. Coen's trading history.
Who are Ginkgo Bioworks' active insiders?: Ginkgo Bioworks' insider roster includes Barry Canton (Major Shareholder), Steven Coen (Chief Financial Officer), Marijn Dekkers (Director), Mark Dmytruk (Insider), Christian Henry (Director), Jason Kelly (Insider), Reshma Shetty (Insider), and Harry Sloan (Director). Learn More on Ginkgo Bioworks' active insiders.
Are insiders buying or selling shares of Ginkgo Bioworks?: In the last twelve months, insiders at the sold shares 7 times. They sold a total of 10,088 shares worth more than $131,747.68. The most recent insider tranaction occured on October, 17th when insider Steven P Coen sold 1,312 shares worth more than $17,908.80. Insiders at Ginkgo Bioworks own 9.7% of the company. Learn More about insider trades at Ginkgo Bioworks.
Information on this page was last updated on 10/17/2025.

Steven P. Coen Insider Trading History at Ginkgo Bioworks

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/17/2025	Sell	1,312	$13.65	$17,908.80	6,738
10/1/2025	Sell	5,609	$15.00	$84,135.00	5,503
7/17/2025	Sell	1,084	$9.84	$10,666.56	10,679
4/21/2025	Sell	997	$7.28	$7,258.16	8,819
3/4/2025	Sell	395	$7.72	$3,049.40	8,012
2/4/2025	Sell	367	$13.44	$4,932.48	7,664
1/6/2025	Sell	324	$11.72	$3,797.28	7,288
12/4/2024	Sell	330	$9.64	$3,181.20	6,869
10/4/2024	Sell	306	$8.35	$2,555.10	6,046
8/2/2024	Sell	17,486	$0.29	$5,070.94	207,318
7/2/2024	Sell	13,520	$0.33	$4,461.60	195,058
6/3/2024	Sell	13,440	$0.55	$7,392.00	178,832

Steven P. Coen Buying and Selling Activity at Ginkgo Bioworks

Ginkgo Bioworks Company Overview

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $9.23

$8.75

$9.41

50 Day Range

MA: $11.58

$7.80

$16.14

2 Week Range

Now: $9.23

$5.00

$17.58

Volume

948,172 shs

Average Volume

1,122,455 shs

Market Capitalization

$558.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54